SAVA Healthcare is a global pharmaceutical manufacturing company offering innovative products like Nasal Sprays and Dry Powdered Inhalers. With WHO-GMP-certified manufacturing and a DSIR-approved R&D facility, we cater to markets across Canada, Ukraine, CIS, Asia, Africa, and FWA. Trusted by leading pharma giants, like Sun Pharma, Alkem, Zydus, Lupin, Macleods, Dr Reddy’s, and Glenmark, we emphasize our product quality, affordability, and innovation excellence.
-
3 Articles
-
2 Photos
-
Vidéos
-
Habitant Pune, Maharashtra
-
Autre
-
01/01/2005
-
Suivi par 0 membre
Rechercher
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Urdu
Portuguese (Brazil)
Greek
Mises à jour récentes
-
Stay Updated with the Latest Pharma News | SAVA Healthcare Press Releases
Get the latest updates on SAVA Healthcare's innovations, partnerships, and industry milestones. As a leading pharmaceutical company, we specialize in nasal sprays, dry powder inhalers, tablets, and more, catering to global healthcare needs. Our press releases cover breakthroughs in R&D, contract manufacturing, and international expansions, reinforcing our commitment to quality and excellence. Stay informed about regulatory approvals, new product launches, and strategic collaborations that shape the future of healthcare.
Read More: https://savaglobal.com/press-releases/Stay Updated with the Latest Pharma News | SAVA Healthcare Press Releases Get the latest updates on SAVA Healthcare's innovations, partnerships, and industry milestones. As a leading pharmaceutical company, we specialize in nasal sprays, dry powder inhalers, tablets, and more, catering to global healthcare needs. Our press releases cover breakthroughs in R&D, contract manufacturing, and international expansions, reinforcing our commitment to quality and excellence. Stay informed about regulatory approvals, new product launches, and strategic collaborations that shape the future of healthcare. Read More: https://savaglobal.com/press-releases/0 Commentaires 0 Parts 53 Vue 0 Aperçu
Plus de lecture